Genetic determinants of the stress response in cardiovascular disease

Metabolism: Clinical and Experimental

Volumn 51, Issue 6 SUPPL. 1, 2002, Pages 15-24

  Hamet, Pavel ^a   Tremblay, Johanne ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; CYTOCHROME P450; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; DOPAMINE RECEPTOR; HEAT SHOCK PROTEIN; HORMONE; LEPTIN; PROTEIN; RYANODINE RECEPTOR; TUMOR NECROSIS FACTOR;

ADAPTATION SYNDROME; BODY TEMPERATURE; CARDIOVASCULAR DISEASE; CELL ONCOGENE; CHROMOSOME 10; COLD PRESSOR TEST; DISTRESS SYNDROME; ENVIRONMENTAL FACTOR; GENE THERAPY; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MEDIATOR RELEASE; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS; REVIEW; SODIUM INTAKE; STRESS;

EID: 0036285777     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.33186     Document Type: Review

References (101)

1. Thymus and adrenals in the response of the organism to injuries and intoxications
2. Forty years of stress research: Principal remaining problems and misconceptions
3. Stressor specificity of central neuroendocrine responses: Implications for stress-related disorders
4. Job characteristics in relation to the prevalence of myocardial infarction in the US Health Examination Survey (HES) and the Health and Nutrition Examination Survey (HANES)
5. Mental stress and its importance for cardiovascular disorders; Physiological aspects, "from-mice-to-man"
6. Cold pressor test as a predictor of hypertension
7. Cardiovascular reactivity to the cold pressor test as a predictor of hypertension
8. Environmental stress and hypertension. Introduction
9. Clinical significance of labile hypertension
10. Increased response to physical and mental stress in men with hypertensive parents
11. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins
12. Prospective study of ambulatory monitoring and echocardiography in borderline hypertension
13. Hypertension: Genes and environment
14. Genetic factors in hypertension
15. Blood pressure trend and psychosocial factors: The case of the nuns in a secluded order
16. Hypersensitivity of spontaneously hypertensive rats (SHR) to heat, ether, and immobilization
17. Thermosensitivity, a possible new locus involved in genetic hypertension
18. Possible involvement of prostaglandins in psychological stress-induced responses in rats
19. Measurements of core temperature in spontaneously hypertensive rats by radiotelemetry
20. Temperature regulation in biotelemetered spontaneously hypertensive rats
21. Influence of environmental temperature on the blood pressure of hypertensive patients in Montreal
22. An analysis of spontaneous hypertension in spontaneously hypertensive rats by means of new recombinant inbred strains
23. Stress modulation by electrolytes in salt-sensitive spontaneously hypertensive rats
24. Search for genetic determinants of environmental susceptibility in hypertension: Effects of heat, immobilization stress and endotoxin
25. Identification of a sex-specific quantitative trait locus mediating nonopioid stress-induced analgesia in female mice
26. Mapping of provisional quantitative trait loci influencing temporal variation in locomotor activity in the LS × SS recombinant inbred strains
27. Genetic analysis of the corticosterone response to ethanol in BXD recombinant inbred mice
28. Quantitative trait loci associated with the behavioral response of B × D recombinant inbred mice to restraint stress: A preliminary communication
29. Contribution of autosomal loci and the Y chromosome to the stress response in rat
30. Mapping of quantitative trait loci (QTL) of differential stress gene expression in rat recombinant inbred strains
31. Heat shock proteins and molecular chaperones: Mediators of protein conformation and turnover in the cell
32. The cellular response to stress
33. Is hsp70 the cellular thermometer?
34. An ATP- and hsc70-dependent oligomerization of nascent heat-shock factor (HSF) polypeptide suggests that HSF itself could be a "sensor" for the cellular stress response
35. In vitro activation of purified human heat shock factor by heat
36. Increased transcription of a major stress gene in spontaneously hypertensive mice
37. Increased accumulation of hsp70 mRNA due to enhanced activation of heat shock transcription factor in spontaneously hypertensive rats
38. Expression of hsp70 gene in lymphocytes from normotensive and hypertensive humans
39. Vascular heat shock protein expression in response to stress - Endocrine and autonomic regulation of this age-dependent response
40. Heat stress genes in hypertension
41. Restriction fragment length polymorphism of hsp70 gene, localized in the RT1 complex, is associated with hypertension in spontaneously hypertensive rats
42. HSP27 locus cosegregates with left ventricular mass independently of blood pressure
43. Pulse rate and twenty-four hour urinary sodium content interact to determine blood pressure levels of male London civil servants
44. Sympathetic tone and relation between sodium intake and blood pressure in the general population
45. Pulse rate and sodium intake interact to determine blood pressure. A population study
46. Stress and high sodium effects on blood pressure and brain catecholamines in spontaneously hypertensive rats
47. Behavioural hypertension in sodium-loaded dogs is accompanied by sustained sodium retention
48. Acute environmental stress overrides cardiac volume receptor reflex in borderline hypertensive rats
49. Chronic immobilization stress reduces sodium intake and renal excretion in rats
50. Psycho-emotional stress-salt intake may interact to raise blood pressure
51. Characteristics of individuals who excrete versus retain sodium under stress
52. Non-modulation as an intermediate phenotype in essential hypertension
53. Sympathetic nervous system influences salt appetite in four strains of rats
54. The molecular neurobiology of stress - Evidence from genetic and epigenetic models
55. A genomic-systems biology map for cardiovascular function
56. Composite trait of blood pressure can be resolved into genetic determinants by sequential pharmacogenetic subtraction of its regulatory systems
57. Heritability of heart rate upon stimulation in members of families with history of hypertension
58. Identification and chromosomal localization of ecogenetic components of electrolyte excretion
59. Layered founders analysis to investigate ancestral genetic transmission of hypertension and obesity in the Saguenay (Quebec) population
60. A cardiovascular EST repertoire: Progress and promise for understanding cardiovascular disease
61. Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays
62. Project Normal: Defining normal variance in mouse gene expression
63. Heart mass and blood pressure have separate genetic determinants in the New Zealand genetically hypertensive (GH) rat
64. Construction of a double congenic strain to prove an epistatic interaction on blood pressure between rat chromosomes 2 and 10
65. Using genetic variation to study human disease
66. Searching for genetic determinants in the new millennium
67. A role of angiotensin II type 1 receptor gene locus in essential hypertension: A study of hypertensive families of French-Canadian origin
68. 2-adrenergic receptor on agonist-mediated vascular desensitization
69. Development of a new strain of rats with inherited stress-induced arterial hypertension
70. Overexpression of dopamine D2 receptors reduces alcohol self-administration
71. Contribution of the TNF alpha gene region of rat chromosome 20 to the body temperature response to endotoxin
72. Role of TNFa gene locus in obesity and obesity-associated hypertension in French-Canadians
73. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
74. ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients
75. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease
76. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: Role of sodium status
77. Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension
78. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure
79. Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies
80. Renal hemodynamic changes induced by captopril and angiotensin-converting enzyme gene polymorphism
81. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
82. Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro
83. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals
84. Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy
85. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene
86. Association of polymorphisms in cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
87. Genetic association between sensitivity to warfarin and expression of CYP2C9*3
88. Are poor metabolisers of sparteine/debrisoquine less pain tolerant than extensive metabolisers?
89. Pharmacogenetics of cancer therapy: Getting personal
90. Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia
91. Pharmacogenetic determination of the effects of codeine and prediction of drug interactions
92. Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence
93. Clinical significance of the sparteine/debrisoquine oxidation polymorphism
94. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites
95. Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers
96. The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone
97. A simple method to calculate resolving power and confidence interval of QTL map location
98. A genetic linkage map of the rat derived from recombinant inbred strains